Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 1
2001 1
2002 1
2003 2
2004 1
2005 2
2006 4
2007 1
2008 2
2009 8
2010 2
2011 10
2012 12
2013 6
2014 5
2015 6
2016 3
2017 4
2018 3
2019 4
2020 3
2021 3
2022 8
2023 2
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.
Porras C, Tsang SH, Herrero R, Guillén D, Darragh TM, Stoler MH, Hildesheim A, Wagner S, Boland J, Lowy DR, Schiller JT, Schiffman M, Schussler J, Gail MH, Quint W, Ocampo R, Morales J, Rodríguez AC, Hu S, Sampson JN, Kreimer AR; Costa Rica Vaccine Trial Group. Porras C, et al. Lancet Oncol. 2020 Dec;21(12):1643-1652. doi: 10.1016/S1470-2045(20)30524-6. Lancet Oncol. 2020. PMID: 33271093 Free PMC article. Clinical Trial.
Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial.
Shing JZ, Hu S, Herrero R, Hildesheim A, Porras C, Sampson JN, Schussler J, Schiller JT, Lowy DR, Sierra MS, Carvajal L, Kreimer AR; Costa Rica HPV Vaccine Trial Group. Shing JZ, et al. Lancet Oncol. 2022 Jul;23(7):940-949. doi: 10.1016/S1470-2045(22)00291-1. Epub 2022 Jun 13. Lancet Oncol. 2022. PMID: 35709811 Free PMC article. Clinical Trial.
Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years.
D'Souza G, Tewari SR, Troy T, Webster-Cyriaque J, Wiley DJ, Lahiri CD, Palella FJ, Gillison ML, Strickler HD, Struijk L, Waterboer T, Ho K, Kwait J, Lazar J, Weber KM, Fakhry C. D'Souza G, et al. Among authors: struijk l. Cancer Epidemiol Biomarkers Prev. 2024 Apr 3;33(4):516-524. doi: 10.1158/1055-9965.EPI-23-1272. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38294704 Free PMC article.
Epidemiology of cutaneous human papillomavirus infections.
Plasmeijer EI, Struijk L, Bouwes Bavinck JN, Feltkamp MC. Plasmeijer EI, et al. Among authors: struijk l. Cancer Treat Res. 2009;146:143-57. doi: 10.1007/978-0-387-78574-5_13. Cancer Treat Res. 2009. PMID: 19415200 Review. No abstract available.
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial.
Shing JZ, Porras C, Pinheiro M, Herrero R, Hildesheim A, Liu D, Gail MH, Romero B, Schiller JT, Zúñiga M, Mishra S, Burdette L, Jones K, Schussler J, Ocampo R, Fang J, Liu Z, Lowy DR, Tsang SH, Rodríguez AC, Schiffman M, Haas CB, Carvajal LJ, Brown JR, Kreimer AR, Mirabello L; Costa Rica HPV Vaccine Trial (CVT) Group. Shing JZ, et al. NPJ Vaccines. 2024 Jun 8;9(1):101. doi: 10.1038/s41541-024-00896-y. NPJ Vaccines. 2024. PMID: 38851816 Free PMC article.
Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial.
Befano B, Campos NG, Egemen D, Herrero R, Schiffman M, Porras C, Lowy DR, Rodriguez AC, Schiller JT, Ocampo R, Hildesheim A, Sampson JN, Das S, Kreimer AR, Cheung LC; Costa Rica HPV Vaccine Trial (CVT) Group. Befano B, et al. J Natl Cancer Inst. 2023 Jul 6;115(7):788-795. doi: 10.1093/jnci/djad064. J Natl Cancer Inst. 2023. PMID: 37040086 Free PMC article.
Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts.
Pagan L, Yfanti C, Rijneveld R, Todd M, Jongste P, Feijen JJ, Klaassen ES, Bouwes Bavinck JN, Struijk L, de Koning MNC, Prestegarden L, Niemeyer-van der Kolk T, van Poelgeest MIE, Rissmann R. Pagan L, et al. Among authors: struijk l. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e773-e775. doi: 10.1111/jdv.18291. Epub 2022 Jun 14. J Eur Acad Dermatol Venereol. 2022. PMID: 35699238 Clinical Trial. No abstract available.
87 results